429 related articles for article (PubMed ID: 33307138)
1. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
Papatheodoridi M; Hiriart JB; Lupsor-Platon M; Bronte F; Boursier J; Elshaarawy O; Marra F; Thiele M; Markakis G; Payance A; Brodkin E; Castera L; Papatheodoridis G; Krag A; Arena U; Mueller S; Cales P; Calvaruso V; de Ledinghen V; Pinzani M; Tsochatzis EA
J Hepatol; 2021 May; 74(5):1109-1116. PubMed ID: 33307138
[TBL] [Abstract][Full Text] [Related]
2. Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
Elhence A; Anand A; Biswas S; Vaishnav M; Yadav R; Das P; Panwar R; Agarwal S; Gamanagatti S; Kumar R; Shalimar
Dig Dis Sci; 2023 Mar; 68(3):1016-1025. PubMed ID: 35670897
[TBL] [Abstract][Full Text] [Related]
3. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.
Pavlov CS; Casazza G; Nikolova D; Tsochatzis E; Burroughs AK; Ivashkin VT; Gluud C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010542. PubMed ID: 25612182
[TBL] [Abstract][Full Text] [Related]
4. Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease.
Zhou YJ; Gao F; Liu WY; Wong GL; Mahadeva S; Raihan Nik Mustapha N; Wang XD; Chan WK; Wong VW; Zheng MH
Aliment Pharmacol Ther; 2021 Aug; 54(4):470-480. PubMed ID: 34152626
[TBL] [Abstract][Full Text] [Related]
5. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
Thorhauge KH; Semmler G; Johansen S; Lindvig KP; Kjærgaard M; Hansen JK; Torp N; Hansen CD; Andersen P; Hofer BS; Gu W; Israelsen M; Mandorfer M; Reiberger T; Trebicka J; Thiele M; Krag A;
J Hepatol; 2024 Jul; 81(1):23-32. PubMed ID: 38428644
[TBL] [Abstract][Full Text] [Related]
6. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
7. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
8. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
[TBL] [Abstract][Full Text] [Related]
9. Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
Grgurevic I; Madir A; Trkulja V; Bozin T; Aralica G; Podrug K; Mikolaševic I; Tsochatzis E; O'Beirne J; Pinzani M
Eur J Clin Invest; 2022 Jun; 52(6):e13750. PubMed ID: 35040495
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
11. Agreement Between 2-Dimensional Shear Wave and Transient Elastography Values for Diagnosis of Advanced Chronic Liver Disease.
Cassinotto C; Lapuyade B; Guiu B; Marraud des Grottes H; Piron L; Merrouche W; Irles-Depe M; Molinari N; De Ledinghen V
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2971-2979.e3. PubMed ID: 32348907
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
[TBL] [Abstract][Full Text] [Related]
13. Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
Yan Y; Xing X; Wang X; Yang L
Eur Radiol; 2022 Mar; 32(3):2078-2088. PubMed ID: 34713329
[TBL] [Abstract][Full Text] [Related]
14. Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography.
He R; Liu C; Grgurevic I; Guo Y; Xu H; Liu J; Liu Y; Wang X; Shi H; Madir A; Podrug K; Zhu Y; Hua Y; Wang K; Wen J; Su M; Zhang Q; Li J; Qi X
Hepatol Int; 2024 Jun; 18(3):1020-1028. PubMed ID: 38740698
[TBL] [Abstract][Full Text] [Related]
15. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study.
Seo YS; Kim MY; Kim SU; Hyun BS; Jang JY; Lee JW; Lee JI; Suh SJ; Park SY; Park H; Jung EU; Kim BS; Kim IH; Lee TH; Um SH; Han KH; Kim SG; Paik SK; Choi JY; Jeong SW; Jin YJ; Lee KS; Yim HJ; Tak WY; Hwang SG; Lee YJ; Lee CH; Kim DG; Kang YW; Kim YS;
Liver Int; 2015 Oct; 35(10):2246-55. PubMed ID: 25682719
[TBL] [Abstract][Full Text] [Related]
17. Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
Lee Y; Kim NH; Kang JH; Cho YS; Kim Y; An J; Sohn JH
Radiology; 2024 Apr; 311(1):e232188. PubMed ID: 38591973
[TBL] [Abstract][Full Text] [Related]
18. Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease.
Shahrani S; Gill SS; Sooi CY; Skantha R; Kumar CVC; Limun MF; Affendi NANM; Chuah KH; Khoo S; Rajaram RB; Chan WK; Mahadeva S
J Gastroenterol Hepatol; 2023 Oct; 38(10):1818-1822. PubMed ID: 37587719
[TBL] [Abstract][Full Text] [Related]
19. Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease.
Kang SH; Baik SK; Kim MY
J Korean Med Sci; 2020 Aug; 35(30):e249. PubMed ID: 32743990
[TBL] [Abstract][Full Text] [Related]
20. Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis.
Szakács Z; Erőss B; Soós A; Mátrai P; Szabó I; Pétervári E; Bajor J; Farkas N; Hegyi P; Illés A; Solymár M; Balaskó M; Sarlós P; Szűcs Á; Czimmer J; Vincze Á; Pár G
Front Physiol; 2019; 10():1028. PubMed ID: 31481896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
